학술논문
S303: A PHASE 3 STUDY (ATLAS‐PPX) TO EVALUATE EFFICACY AND SAFETY OF FITUSIRAN IN PEOPLE WITH HAEMOPHILIA A OR B WHO HAVE SWITCHED FROM PRIOR CLOTTING FACTOR CONCENTRATE OR BYPASSING AGENT PROPHYLAXIS.
Document Type
Article
Author
Kenet, Gili; Nolan, Beatrice; Zulfikar, Bulent; Antmen, Bulent; Kampmann, Peter; Matsushita, Tadashi; You, Chur‐Woo; Vilchevska, Kateryna; Bag, Catherine N.; Sharif, Azizan; Peyvandi, Flora; Young, Guy; Negrier, Claude; Sussebach, Christian; Shammas, Fadi; Andersson, Shauna; Mei, Baisong; Kavakli, Kaan
Source
HemaSphere; 2023 Supplement 3, Vol. 7, p1-3, 3p
Subject
Language
ISSN
25729241